Bayer AG (BAYRY – Free Report) announced a restructuring plan to streamline business and improve efficiency.
The company plans to exit its Animal Health business, and management is currently assessing various options for this business. The decision to exit this business comes as part of the companys plan to focus on its core businesses of Pharmaceuticals, Consumer Health and Crop Science.
The company is making efforts to revive its Consumer Health division to target market growth in the coming years and improve profitability. The measures include a planned exit from product categories, which were not suiting the companys business model. In addition to the previously announced divestment of prescription dermatology p…
Read the full article at: https://www.zacks.com/stock/news/340344/Bayer-BAYRY-to-Restructure-Business-amp-Reduce-Headcount